The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
How will HPV vaccines affect cervical cancer?
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Papillomaviruses and cancer: from basic studies to clinical application
zur Hausen, H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc798 · Cited by 4,024
The causal relation between human papillomavirus and cervical cancer
Bosch, F. X., Lorincz, A., Munoz, N., Meijer, C. J. L. M., & Shah, K. V. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.4.244 · Cited by 3,538
Classification of papillomaviruses
de Villiers, E.-M., Fauquet, C., Broker, T. R., Bernard, H.-U., & zur Hausen, H. (2004) · Virology · doi:10.1016/j.virol.2004.03.033 · Cited by 3,193
Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers
Gillison, M. L. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.9.709 · Cited by 3,101
The global health burden of infection‐associated cancers in the year 2002
Parkin, D. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21731 · Cited by 2,932
Natural History of Cervicovaginal Papillomavirus Infection in Young Women
Ho, G. Y. F., Bierman, R., Beardsley, L., Chang, C. J., & Burk, R. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380703 · Cited by 2,329
NATURAL HISTORY OF CERVICOVAGINAL PAPILLOMAVIRUS INFECTION IN YOUNG WOMEN
Loria, G. R., Ierman, R. O. B., Eardsley, L. E. B., & Hang, H. J. C. (1998) · Cited by 1,890
Harper, D. M., Franco, E. L., Wheeler, C., Ferris, D. G., Jenkins, D., Schuind, A., Zahaf, T., Innis, B., Naud, P., De Carvalho, N. S., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17398-4 · Cited by 1,643
Harper, D. M., Franco, E. L., Wheeler, C. M., Moscicki, A.-B., Romanowski, B., Roteli-Martins, C. M., Jenkins, D., Schuind, A., Costa Clemens, S. A., & Dubin, G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68439-0 · Cited by 1,632
A Controlled Trial of a Human Papillomavirus Type 16 Vaccine
Koutsky, L. A., Ault, K. A., Wheeler, C. M., Brown, D. R., Barr, E., Alvarez, F. B., Chiacchierini, L. M., & Jansen, K. U. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020586 · Cited by 1,602
Villa, L. L., Costa, R. L., Petta, C. A., Andrade, R. P., Ault, K. A., Giuliano, A. R., Wheeler, C. M., Koutsky, L. A., Malm, C., Lehtinen, M., et al. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70101-7 · Cited by 1,579
Kirnbauer, R., Booy, F., Cheng, N., Lowy, D. R., & Schiller, J. T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12180 · Cited by 1,110
Muñoz, N., Bosch, F. X., Castellsagué, X., Díaz, M., de Sanjose, S., Hammouda, D., Shah, K. V., & Meijer, C. J. L. M. (2004) · International Journal of Cancer · doi:10.1002/ijc.20244 · Cited by 1,104
Clifford, G., Gallus, S., Herrero, R., Muñoz, N., Snijders, P., Vaccarella, S., Anh, P., Ferreccio, C., Hieu, N., Matos, E., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67069-9 · Cited by 1,093
Clifford, G. M., Polesel, J., Rickenbach, M., Study, O. B. O. T. S. H. C., Dal Maso, L., Keiser, O., Kofler, A., Rapiti, E., Levi, F., Jundt, G., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji072 · Cited by 863
Mechanisms of human papillomavirus-induced oncogenesis
Münger, K., Baldwin, A., Edwards, K. M., Hayakawa, H., Nguyen, C. L., Owens, M., Grace, M., & Huh, K. (2004) · Journal of Virology · doi:10.1128/jvi.78.21.11451-11460.2004 · Cited by 815
Male Circumcision, Penile Human Papillomavirus Infection, and Cervical Cancer in Female Partners
Castellsagué, X., Bosch, F. X., Muñoz, N., Meijer, C. J. L. M., Shah, K. V., de Sanjosé, S., Eluf-Neto, J., Ngelangel, C. A., Chichareon, S., Smith, J. S., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011688 · Cited by 804
HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes
Hawley‐Nelson, P., Vousden, K. H., Hubbert, N. L., Lowy, D. R., & Schiller, J. T. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08570.x · Cited by 733
Salazar, K. L., Zhou, H. S., Xu, J., Peterson, L. E., Schwartz, M. R., Mody, D. R., & Ge, Y. (2015) · Acta Cytologica · doi:10.1159/000442512 · Cited by 721
Condom Use and the Risk of Genital Human Papillomavirus Infection in Young Women
Winer, R. L., Hughes, J. P., Feng, Q., O'Reilly, S., Kiviat, N. B., Holmes, K. K., & Koutsky, L. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053284 · Cited by 694
Suzich, J. A., Ghim, S. J., Palmer-Hill, F. J., White, W. I., Tamura, J. K., Bell, J. A., Newsome, J. A., Jenson, A. B., & Schlegel, R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11553 · Cited by 668
Harro, C. D., Pang, Y.-Y. S., Roden, R. B. S., Hildesheim, A., Wang, Z., Reynolds, M. J., Mast, T. C., Robinson, R., Murphy, B. R., Karron, R. A., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.284 · Cited by 607
Self-citationBreitburd, F., Kirnbauer, R., Hubbert, N. L., Nonnenmacher, B., Trin-Dinh-Desmarquet, C., Orth, G., Schiller, J. T., & Lowy, D. R. (1995) · Journal of Virology · doi:10.1128/jvi.69.6.3959-3963.1995 · Cited by 589
Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine
Goldie, S. J., Kohli, M., Grima, D., Weinstein, M. C., Wright, T. C., Bosch, F. X., & Franco, E. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh104 · Cited by 539
Epidemiologic Evidence and Human Papillomavirus Infection as a Necessary Cause of Cervical Cancer
Franco, E. L., Rohan, T. E., & Villa, L. L. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.6.506 · Cited by 533
Structure of Small Virus-like Particles Assembled from the L1 Protein of Human Papillomavirus 16
Chen, X. S., Garcea, R. L., Goldberg, I., Casini, G., & Harrison, S. C. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80449-9 · Cited by 471
THE PROGRESSION TO CARCINOMA OF VIRUS-INDUCED RABBIT PAPILLOMAS (SHOPE)
Rous, P., & Beard, J. W. (1935) · Journal of Experimental Medicine · doi:10.1084/jem.62.4.523 · Cited by 455
Biosynthesis of Human Papillomavirus from a Continuous Cell Line Upon Epithelial Differentiation
Meyers, C., Frattini, M. G., Hudson, J. B., & Laimins, L. A. (1992) · Science · doi:10.1126/science.1323879 · Cited by 455
Mao, C., Koutsky, L. A., Ault, K. A., Wheeler, C. M., Brown, D. R., Wiley, D. J., Alvarez, F. B., Bautista, O. M., Jansen, K. U., & Barr, E. (2006) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000192397.41191.fb · Cited by 451
Robbins, J. B., Schneerson, R., & Szu, S. C. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.6.1387 · Cited by 385
Rose, R. C., Bonnez, W., Reichman, R. C., & Garcea, R. L. (1993) · Journal of Virology · doi:10.1128/jvi.67.4.1936-1944.1993 · Cited by 381
Evaluating Human Papillomavirus Vaccination Programs
Taira, A. V., Neukermans, C. P., & Sanders, G. D. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1011.040222 · Cited by 379
Spinning molecular immunology into successful immunotherapy
Pardoll, D. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri774 · Cited by 360
Greenstone, H. L., Nieland, J. D., de Visser, K. E., Bruijn, M. L. H. D., Kirnbauer, R., Roden, R. B. S., Lowy, D. R., Kast, W. M., & Schiller, J. T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1800 · Cited by 325
Self-citationSolid Cancers After Bone Marrow Transplantation
Bhatia, S., Louie, A. D., Bhatia, R., O’Donnell, M. R., Fung, H., Kashyap, A., Krishnan, A., Molina, A., Nademanee, A., Niland, J. C., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.464 · Cited by 316
Virus-like Particles of Bovine Papillomavirus Type 4 in Prophylactic and Therapeutic Immunization
KIRNBAUER, R., CHANDRACHUD, L. M., O'NEIL, B. W., WAGNER, E. R., GRINDLAY, G. J., ARMSTRONG, A., McGARVIE, G. M., SCHILLER, J. T., LOWY, D. R., & CAMPO, M. S. (1996) · Virology · doi:10.1006/viro.1996.0220 · Cited by 313
A quantitative in vitro focus assay for bovine papilloma virus
Dvoretzky, I., Shober, R., Chattopadhyay, S. K., & Lowy, D. R. (1980) · Virology · doi:10.1016/0042-6822(80)90195-6 · Cited by 304
Barnabas, R. V., Laukkanen, P., Koskela, P., Kontula, O., Lehtinen, M., & Garnett, G. P. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030138 · Cited by 293
Liaw, K., Hildesheim, A., Burk, R. D., Gravitt, P., Wacholder, S., Manos, M. M., Scott, D. R., Sherman, M. E., Kurman, R. J., Glass, A. G., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/317638 · Cited by 291
The Promise of Global Cervical-Cancer Prevention
Schiffman, M., & Castle, P. E. (2005) · New England Journal of Medicine · doi:10.1056/nejmp058171 · Cited by 286
Roden, R. B., Greenstone, H. L., Kirnbauer, R., Booy, F. P., Jessie, J., Lowy, D. R., & Schiller, J. T. (1996) · Journal of Virology · doi:10.1128/jvi.70.9.5875-5883.1996 · Cited by 275
Self-citationRole of Herd Immunity in Determining the Effect of Vaccines against Sexually Transmitted Disease
Garnett, G. P. (2005) · The Journal of Infectious Diseases · doi:10.1086/425271 · Cited by 244
Trimble, C. L., Piantadosi, S., Gravitt, P., Ronnett, B., Pizer, E., Elko, A., Wilgus, B., Yutzy, W., Daniel, R., Shah, K., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2599 · Cited by 234
Self-citationThe Theoretical Population-Level Impact of a Prophylactic Human Papilloma Virus Vaccine
Hughes, J. P., Garnett, G. P., & Koutsky, L. (2002) · Epidemiology · doi:10.1097/00001648-200211000-00006 · Cited by 230
Barr, E., & Koutsky, L. A. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh071 · Cited by 230
Christensen, N. D., Reed, C. A., Cladel, N. M., Han, R., & Kreider, J. W. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.960-965.1996 · Cited by 220
Nardelli-Haefliger, D., Wirthner, D., Schiller, J. T., Lowy, D. R., Hildesheim, A., Ponci, F., & De Grandi, P. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg018 · Cited by 207
Evans, T. G., Bonnez, W., Rose, R. C., Koenig, S., Demeter, L., Suzich, J. A., O'Brien, D., Campbell, M., White, W. I., Balsley, J., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/320190 · Cited by 187
Chimeric Papillomavirus-like Particles
Müller, M., Zhou, J., Reed, T. D., Rittmüller, C., Burger, A., Gabelsberger, J., Braspenning, J., & Gissmann, L. (1997) · Virology · doi:10.1006/viro.1997.8591 · Cited by 177
Rapid induction of senescence in human cervical carcinoma cells
Goodwin, E. C., Yang, E., Lee, C.-J., Lee, H.-W., DiMaio, D., & Hwang, E.-S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.20.10978 · Cited by 176
de Jong, A., O’Neill, T., Khan, A. Y., Kwappenberg, K. M. C., Chisholm, S. E., Whittle, N. R., Dobson, J. A., Jack, L. C., St Clair Roberts, J., Offringa, R., et al. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00350-x · Cited by 166
Cutting Edge: Priming of CTL by Transcutaneous Peptide Immunization with Imiquimod
Rechtsteiner, G., Warger, T., Osterloh, P., Schild, H., & Radsak, M. P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2476 · Cited by 164
HPV6b virus like particles are potent immunogens without adjuvant in man
Zhang, L. (2000) · Vaccine · doi:10.1016/s0264-410x(99)00351-5 · Cited by 163
Sasagawa, T., Pushko, P., Steers, G., et al. (1995) · Virology · doi:10.1016/s0042-6822(95)80027-1 · Cited by 162
Nardelli-Haefliger, D., Roden, R. B., Benyacoub, J., Sahli, R., Kraehenbuhl, J. P., Schiller, J. T., Lachat, P., Potts, A., & De Grandi, P. (1997) · Infection and Immunity · doi:10.1128/iai.65.8.3328-3336.1997 · Cited by 160
Self-citationImmunization with a Pentameric L1 Fusion Protein Protects against Papillomavirus Infection
Yuan, H., Estes, P. A., Chen, Y., Newsome, J., Olcese, V. A., Garcea, R. L., & Schlegel, R. (2001) · Journal of Virology · doi:10.1128/jvi.75.17.7848-7853.2001 · Cited by 154
Interaction of papillomaviruses with the cell surface
Roden, R. B. S., Kirnbauer, R., Jenson, A. B., Lowy, D. R., & Schiller, J. T. (1994) · Journal of Virology · doi:10.1128/jvi.68.11.7260-7266.1994 · Cited by 149
Self-citationLin, Y., Borenstein, L. A., Selvakumar, R., et al. (1992) · Virology · doi:10.1016/0042-6822(92)90463-y · Cited by 149
Papillomavirus DNA Replication
Chow, L. T., & Broker, T. R. (1994) · Intervirology · doi:10.1159/000150373 · Cited by 145
Human papillomavirus in a necessary cause of invasive cervical cancer worldwide
(1999) · Pure Amsterdam UMC · doi:10.1002/(sici)1096-9896(199909)189:1 · Cited by 140
Gravitt, P. E., Lacey, J. V., Brinton, L. A., Barnes, W. A., Kornegay, J., Greenberg, M., Greene, S. M., Hadjimichael, O. C., McGowan, L., Mortel, R., et al. (2001) · PubMed · Cited by 139
Women's desired information about human papillomavirus
Anhang, R., Wright, T. C., Smock, L., & Goldie, S. J. (2004) · Cancer · doi:10.1002/cncr.20007 · Cited by 131
Li, M., Cripe, T. P., Estes, P. A., Lyon, M. K., Rose, R. C., & Garcea, R. L. (1997) · Journal of Virology · doi:10.1128/jvi.71.4.2988-2995.1997 · Cited by 129
Smyth, L. J. C., van Poelgeest, M. I. E., Crosbie, E. J., Kwappenberg, K. M. C., Burt, D., Sehr, P. A., Pawlita, M., Man, S., Hickling, J., Fiander, A., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0703 · Cited by 128
White, W. I., Wilson, S. D., Bonnez, W., Rose, R. C., Koenig, S., & Suzich, J. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.959-964.1998 · Cited by 124
Human Papillomavirus Type 11 Recombinant L1 Capsomeres Induce Virus-Neutralizing Antibodies
Rose, R. C., White, W. I., Li, M., Suzich, J., Lane, C., & Garcea, R. L. (1998) · Journal of Virology · doi:10.1128/jvi.72.7.6151-6154.1998 · Cited by 120
Dürst, M., Bosch, F. X., Glitz, D., Schneider, A., & Hausen, H. Z. (1991) · Journal of Virology · doi:10.1128/jvi.65.2.796-804.1991 · Cited by 112
NHPV16 VLP Vaccine Induces Human Antibodies That Neutralize Divergent Variants of HPV16
Pastrana, D. V., Vass, W. C., Lowy, D. R., & Schiller, J. T. (2001) · Virology · doi:10.1006/viro.2000.0702 · Cited by 110
Ethical analysis of HPV vaccine policy options
Zimmerman, R. K. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.03.019 · Cited by 110
Recurrent Respiratory Papillomatosis
Kashima, H. K., & Shah, K. V. (1987) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(21)00073-5 · Cited by 109
Nardelli‐Haefliger, D., Lurati, F., Wirthner, D., et al. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.02.019 · Cited by 103
A phase I study to evaluate a human papillomavirus (HPV) type 18 L1 VLP vaccine
Ault, K. A., Giuliano, A. R., Edwards, R. P., Tamms, G. M., Kim, L.-L., Smith, J. F., Jansen, K. U., Allende, M. C., Taddeo, F. J., Skulsky, D., et al. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.02.020 · Cited by 99
The Potential of Human Papillomavirus Vaccines
Steinbrook, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmp058305 · Cited by 94
Koshiol, J. E., Schroeder, J. C., Jamieson, D. J., Marshall, S. W., Duerr, A. C., Heilig, C. M., Shah, K. V., Klein, R. S., Cu‐Uvin, S., Schuman, P. C., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.22015 · Cited by 93
Early assessment of the efficacy of a human papillomavirus type 16 L1 virus-like particle vaccine
Brown, D. R., Fife, K. H., Wheeler, C. M., Koutsky, L. A., Lupinacci, L. C., Railkar, R. A., Suhr, G., Barr, E., DiCELLO, A. C., Li, W., et al. (2004) · Vaccine · doi:10.1016/j.vaccine.2003.11.059 · Cited by 88
From Papanicolaou to Bethesda: The rationale for a new cervical cytologic classification
Kurman, R. J., Malkasian, G. D., Sedlis, A., & Solomon, D. (1992) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(92)90061-m · Cited by 83
Cornejo‐Juárez, P., Volkow-Fernández, P. A., Escobedo-Lopez, K. M., et al. (2006) · AIDS Research and Therapy · doi:10.1186/1742-6405-3-9 · Cited by 75
Reuter, J. D., Vivas-Gonzalez, B. E., Gomez, D., Wilson, J. H., Brandsma, J. L., Greenstone, H. L., Rose, J. K., & Roberts, A. (2002) · Journal of Virology · doi:10.1128/jvi.76.17.8900-8909.2002 · Cited by 72
Silins, I., Wang, Z., Lundqvist, E. Å., Frankendal, B., Vikmanis, U., Sapp, M. J., Schiller, J. T., & Dillner, J. (1999) · Journal of General Virology · doi:10.1099/0022-1317-80-11-2931 · Cited by 70
Evidence for the coexistence of two genital HPV types within the same host cell in vitro
McLaughlin-Drubin, M. E., & Meyers, C. (2004) · Virology · doi:10.1016/j.virol.2003.12.019 · Cited by 46
Human papillomavirus-associated malignancies in HIV-positive men and women
Palefsky, J. M. (1995) · Current Opinion in Oncology · doi:10.1097/00001622-199509000-00009 · Cited by 45
Ekalaksananan, T., Pientong, C., Sriamporn, S., Kongyingyoes, B., Pengsaa, P., Kleebkaow, P., Kritpetcharat, O., & Parkin, D. M. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.01.033 · Cited by 43
Govan, V. A., Christensen, N. D., Berkower, C. L., Jacobs, W. R., & Williamson, A. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.11.029 · Cited by 31
Human Papillomaviruses and Cell Signaling
McCance, D. J. (2005) · Science s STKE · doi:10.1126/stke.2882005pe29 · Cited by 17
Cited by
The natural history of cervical HPV infection: unresolved issues
Woodman, C. B. J., Collins, S. I., & Young, L. S. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2050 · Cited by 1,033
Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities
Gakidou, E., Nordhagen, S., & Obermeyer, Z. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050132 · Cited by 976
DNA vaccine for cancer immunotherapy
Yang, B., Jeang, J., Yang, A., Wu, T. C., & Hung, C.-F. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/21645515.2014.980686 · Cited by 276
Self-citation
Metadata
- Authors
- Roden, R., & Wu, T.-C.
- Venue
- Nature Reviews Cancer
- Published
- 2006-10-01
- Volume
- 6
- Issue
- 10
- Pages
- 753-763
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1966392449
- Cited by
- 283
- References
- 85
- FWCI
- 4.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.